يعرض 2,001 - 2,020 نتائج من 13,825 نتيجة بحث عن '(( significant increase decrease ) OR ( significant ((small decrease) OR (point decrease)) ))*', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 2001
  2. 2002
  3. 2003
  4. 2004

    Initial participants by wave*. حسب Yeo Ju Sohn (18536198)

    منشور في 2024
    الموضوعات:
  5. 2005
  6. 2006
  7. 2007
  8. 2008
  9. 2009
  10. 2010
  11. 2011
  12. 2012

    CHAMPS pilot Hb dataset. حسب Jeanie du Toit (20721918)

    منشور في 2025
    "…Postmortem testing showed a significant decrease in hemoglobin concentrations compared to antemortem levels. …"
  13. 2013
  14. 2014

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  15. 2015

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  16. 2016

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  17. 2017
  18. 2018
  19. 2019
  20. 2020